View in EDS

Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial.

Saved in:
Bibliographic Details
Title: Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial.
Authors: Tate M; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Illingworth CJR; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., MacGregor G; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Cunningham L; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., Divers L; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., McCartney E; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., Paterson L; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., Kelly C; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., Shaw A; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., Perkins JS; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Silva V; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Holland P; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Dalton C; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Carmichael S; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Douglas E; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Surtees P; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Scott JT; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Berry C; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Vattipally S; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Da Silva Filipe A; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Tong L; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Gunson R; West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, United Kingdom., McInnes IB; School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom., Jones R; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom., Thomson E; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.; School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom., Blyth KG; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Scotland Institute, Glasgow, United Kingdom.
Corporate Authors: GETAFIX trial co-investigators
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Aug 06; Vol. 69 (8), pp. e0005425. Date of Electronic Publication: 2025 Jun 24.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40552814
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tate+M%22">Tate M</searchLink>; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Illingworth+CJR%22">Illingworth CJR</searchLink>; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22MacGregor+G%22">MacGregor G</searchLink>; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cunningham+L%22">Cunningham L</searchLink>; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Divers+L%22">Divers L</searchLink>; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McCartney+E%22">McCartney E</searchLink>; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Paterson+L%22">Paterson L</searchLink>; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kelly+C%22">Kelly C</searchLink>; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Shaw+A%22">Shaw A</searchLink>; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Perkins+JS%22">Perkins JS</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Silva+V%22">Silva V</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Holland+P%22">Holland P</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dalton+C%22">Dalton C</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carmichael+S%22">Carmichael S</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Douglas+E%22">Douglas E</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Surtees+P%22">Surtees P</searchLink>; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Scott+JT%22">Scott JT</searchLink>; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Berry+C%22">Berry C</searchLink>; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vattipally+S%22">Vattipally S</searchLink>; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Da+Silva+Filipe+A%22">Da Silva Filipe A</searchLink>; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tong+L%22">Tong L</searchLink>; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gunson+R%22">Gunson R</searchLink>; West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McInnes+IB%22">McInnes IB</searchLink>; School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jones+R%22">Jones R</searchLink>; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK-Glasgow Clinical Trials Unit, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thomson+E%22">Thomson E</searchLink>; MRC University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.; School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Blyth+KG%22">Blyth KG</searchLink>; Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Scotland Institute, Glasgow, United Kingdom.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22GETAFIX+trial+co-investigators%22">GETAFIX trial co-investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2025 Aug 06; Vol. 69 (8), pp. e0005425. <i>Date of Electronic Publication: </i>2025 Jun 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40552814
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1128/aac.00054-25
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0005425
    Titles:
      – TitleFull: Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tate M
      – PersonEntity:
          Name:
            NameFull: Illingworth CJR
      – PersonEntity:
          Name:
            NameFull: MacGregor G
      – PersonEntity:
          Name:
            NameFull: Cunningham L
      – PersonEntity:
          Name:
            NameFull: Divers L
      – PersonEntity:
          Name:
            NameFull: McCartney E
      – PersonEntity:
          Name:
            NameFull: Paterson L
      – PersonEntity:
          Name:
            NameFull: Kelly C
      – PersonEntity:
          Name:
            NameFull: Shaw A
      – PersonEntity:
          Name:
            NameFull: Perkins JS
      – PersonEntity:
          Name:
            NameFull: Silva V
      – PersonEntity:
          Name:
            NameFull: Holland P
      – PersonEntity:
          Name:
            NameFull: Dalton C
      – PersonEntity:
          Name:
            NameFull: Carmichael S
      – PersonEntity:
          Name:
            NameFull: Douglas E
      – PersonEntity:
          Name:
            NameFull: Surtees P
      – PersonEntity:
          Name:
            NameFull: Scott JT
      – PersonEntity:
          Name:
            NameFull: Berry C
      – PersonEntity:
          Name:
            NameFull: Vattipally S
      – PersonEntity:
          Name:
            NameFull: Da Silva Filipe A
      – PersonEntity:
          Name:
            NameFull: Tong L
      – PersonEntity:
          Name:
            NameFull: Gunson R
      – PersonEntity:
          Name:
            NameFull: McInnes IB
      – PersonEntity:
          Name:
            NameFull: Jones R
      – PersonEntity:
          Name:
            NameFull: Thomson E
      – PersonEntity:
          Name:
            NameFull: Blyth KG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 08
              Text: 2025 Aug 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1098-6596
          Numbering:
            – Type: volume
              Value: 69
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Antimicrobial agents and chemotherapy
              Type: main
ResultId 1